NIH-funded research NIH-funded research

Improving cervical cancer screening and treatment in low-resource settings

Official title: Research Project 2

Funded at Columbia University Health Sciences · NIH-10931485 · Data updated 2026-11-12

This study is looking at a new way to help women in South Africa get tested and treated for cervical cancer more easily and affordably, using a quick HPV test that can be done right in their local clinics.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 19, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$179,287
NIH project number5U54CA284030-02
Project IDNIH-10931485 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women living in low and middle-income countries, particularly those in public primary care settings who are at risk for cervical cancer.

Less likely to help

Patients who do not reside in low and middle-income countries or those who are not at risk for cervical cancer may not benefit from this research.

What this research studies

This research focuses on enhancing cervical cancer screening and treatment in low and middle-income countries, particularly through the implementation of HPV-based testing followed by immediate treatment. It aims to evaluate the costs and effectiveness of a new point-of-care HPV DNA test in public primary care settings in South Africa. By collaborating with local institutions, the project seeks to develop tailored strategies for the widespread adoption of this screening method, addressing both financial and operational challenges. The study will assess the cost-effectiveness of the screening process to ensure equitable access for women in these communities.

Why it matters

Potential benefit: If successful, this research could significantly reduce cervical cancer mortality rates among women in low-resource settings by improving access to effective screening and treatment.

How similar studies have gone: Previous research has shown success with similar HPV-based screening approaches, indicating potential for effective implementation in diverse settings.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Moodley, Jennifer Rose — Columbia University Health Sciences
  • Study coordinator: Moodley, Jennifer Rose

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.